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Abstract
The growing number of atrial fibrillation catheter ablation 
procedures warranted the development of advanced 
cardiac mapping techniques, such as image integration 
between electroanatomical map and cardiac computed 
tomography. While scanning the chest before catheter 
ablation, it is frequent to detect cardiac and extracardiac 
collateral findings. Most collateral findings are promptly 
recognized as benign and do not require further atten-
tion. However, sometimes clinically relevant collateral 
findings are detected, which often warrant extra diag-
nostic examinations or even invasive procedure, and 
sometimes need to be followed-up over time. Even 
though reporting and further investigating collateral 
findings has not shown a clear survival benefit, almost all 
the working groups providing data on collateral findings 
reported some collateral findings eventually coming 
out to be malignancies, sometimes at an early stage. 
Therefore, there is currently no clear agreement about 
the right strategy to be followed.
Key words: Collateral findings; Incidental findings; 
Incidentalomas; Cardiac computed tomography; Image 
integration
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Core tip: Several cardiac computed tomography (CT) 
scans are performed worldwide in order to better delineate 
left atrial anatomy before atrial fibrillation (AF) ablation. 
A thorough examination of the entire field of view often 
discovers cardiac or extra-cardiac collateral findings, 
which might represent potentially malignant diseases. 
Early detection of such diseases may guarantee a curative 
treatment. Our objective is to consolidate the current 
literature about collateral findings detected at cardiac 
CT before AF ablation and to highlight the potential 
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implications of systematically reporting and following up 
such findings.
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IMAGE INTEGRATION IN ATRIAL 
FIBRILLATION ABLATION
Cardiac computed tomography (CT) is being increasingly 
required for a large amount of indications, such as 
coronary artery disease, congenital heart disease, and 
detection of intracardiac thrombi[1]. It is also frequently 
performed among patients undergoing atrial fibrillation (AF) 
catheter ablation, in order to achieve three-dimensional 
reconstruction of the left atrium (LA), which is crucial 
for pre-procedural planning of the ablation strategy and 
accurate intra-procedural catheter navigation, especially in 
complex cardiac anatomies[2-4]. 
Pulmonary vein (PV) isolation has become a corner-
stone in the treatment of AF, and may represent a first-
line therapy in selected cases[5-8]. However, complicated LA 
or PV anatomy can make it extremely difficult to access 
some areas, thus contributing to suboptimal success 
rates and hindering the successful application of this 
technique[9,10]. Moreover, it has been ascertained that PV 
anatomic variations are fairly common[11-13]. Knowledge of 
the conventional pulmonary venous anatomy, as well as 
of anatomic variants, is crucial for preprocedural planning 
and safer catheter navigation. Fluoroscopy alone cannot 
differentiate between PVs, LA and surrounding structures. 
On this proposal, cardiac CT has gained acceptance, 
among cardiac electrophysiologists, as the preferred 
radiological investigation in order to precisely delineate 
LA and PV anatomy, because of its better diagnostic gain 
on intrathoracic organs and vessels as compared to other 
investigations, such as intracardiac echocardiography[14]; 
moreover, cardiac CT is more widely available than mag-
netic resonance, requires shorter scanning times and is 
better tolerated by patients[2-4,15]. These characteristics 
made cardiac CT the gold standard exam for image 
integration in AF ablation. 
Cardiac CT performed for AF ablation is a chest CT 
angiography scan acquired using multidetector CT scanners 
with a field of view (FOV) which usually extends vertically 
from the level of the carina to the diaphragm. CT scan 
is generally not electrocardiographically (ECG)-gated, 
since a consistent part of the patients may be in AF 
during the examination. The absence of ECG-gating is 
the main difference between cardiac CT scan performed 
for AF ablation and for coronary artery disease, since 
synchronization with the ECG is necessary in order to 
investigate coronary arteries. Scan synchronization with 
the contrast medium is often performed with the bolus 
tracking technique, that is, injecting a bolus of radio-
opaque contrast media into the patient via a peripheral 
vein, tracking the volume of contrast within a region of 
interest, and then following it with the CT scanner after 
it reaches that region. After imaging the left atrium, it is 
possible to build a volume rendering three-dimensional 
image of the structures of interest, which is imported in 
the electroanatomical mapping system workstation and 
segmented using an image processing software, in order 
to better distinguish the left atrium from the surrounding 
structures. Once the segmentation process is complete, 
the three-dimensional representation of the left atrium is 
displayed in the electroanatomical mapping system and is 
superimposed to the three-dimensional electroanatomical 
map created by the operator; the electroanatomical map 
and the CT image are aligned to each other in order to 
allow the operator to move the mapping catheter within 
the three-dimensional representation of the left atrium.
Image integration between the cardiac CT scan 
(performed before the ablation) and the electroanatomical 
LA map (obtained intraprocedurally), allows the operator 
to have a detailed roadmap of the actual patient’s anatomy 
available during the ablation procedure. This is crucial for 
anatomic definition of ablation targets and precise catheter 
navigation throughout complex anatomies, as well as for 
limiting collateral damage to adjacent structures, such 
as the esophagus (lowering the risk of atrio-esophageal 
fistula)[16]. This technique is particularly useful while 
ablating difficult targets, such as the ridge of Marshall 
between the left-sided PVs and the left atrial appendage, 
in order to avoid ablating either inside the appendage 
(risk of perforation) or too deep inside the PVs (risk of PV 
stenosis) (Figure 1). Image integration systems have been 
shown to reduce procedural and fluoroscopy times, and 
even improve procedural outcomes, thus justifying their 
increased procedural costs[17-19].
COLLATERAL FINDINGS DETECTED 
BY CARDIAC CT FOR AF CATHETER 
ABLATION
Cardiac CT scan usually details only a small FOV strictly 
around the heart, although almost the entire chest is 
irradiated during image acquisition. A larger FOV is then 
available from the unprocessed data to examine the 
neighboring structures, such as lungs, breasts, media–
stinum, spine, and upper abdomen, with no additional 
X-rays exposure. While examining the entire FOV of a 
cardiac CT, it is frequent to encounter cardiac or extra-
cardiac collateral findings (CFs) during the imaging study 
(Figures 2 and 3). The term “collateral finding” reflects 
an incidentally discovered mass or lesion, detected by CT, 
magnetic resonance imaging, or other imaging modality, 
which is not related to the primary objectives of the 
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examination; CFs are also called “incidental findings” 
or “incidentalomas”[20]. A collateral finding is considered 
“clinically significant” when its detection warrants further 
investigations or therapeutic measures, or causes a 
change in the patient management. Most encountered 
extra-cardiac CFs pertain to the lungs, particularly small 
(< 4 mm) pulmonary nodules. Other frequently met CFs 
are degenerative spine disease, aortic disease, swollen 
mediastinal or hilar lymph nodes, liver lesions.
On this basis, several working groups reported about 
the prevalence and clinical significance of such CFs during 
cardiac CT scans. The early reports mostly referred to 
CT studies performed in order to diagnose coronary 
artery disease, which is the main indication for cardiac 
CT scan[21-25]. The reported prevalence of CFs during 
4 electron beam CT studies ranged between 7.8% to 
53%, with 4.2% to 11% of scanned patients needing 
follow-up examinations; this wide range of prevalence 
can be explained by different technologies and definition 
of CFs used in those studies[26-29]. Along with the 
expanding indications for AF catheter ablation, there 
has been a parallel growth in the request of cardiac CT 
to depict LA and PV anatomy for image integration. As 
a consequence, some studies reporting CFs detected 
before AF ablation have been published (Table 1)[30-35].
Wissner et al[30] studied 95 patients undergoing PV 
isolation between 2003 and 2007 with a 16-slice and 
subsequently 64-slice multidetector scanner, covering an 
area from above the clavicle to diaphragm, and found 
that 53% of patients had either cardiac or extracardiac 
CFs. Most CFs were extracardiac (78 out of 83), and 
more than half (46 out of 83) were pulmonary. Fifteen 
patients (16%) needed additional tests, and 6 of them 
(6.8%) had therapeutic implications due to the detection 
of unexpected findings. One patient (1.1%) had an 
adenocarcinoma of the lung diagnosed, which was treated 
surgically[30].
Sohns et al[31] performed 64-slice multidetector CT 
of the chest and upper abdomen in 158 patients for 
identification of PV anatomy. They looked for extracardiac 
CFs only. A total of 198 extracardiac CFs were detected 
in 72% of patients, and 31% of patients had at least one 
clinically significant or potentially significant finding. Lung 
cancer was diagnosed in 2 patients (1.3%)[31].
The same group assessed the incidence of both cardiac 
and extracardiac CFs among an extended population 
of 224 AF patients. In 91% of patients an average 
of 3.2 cardiac findings per patient were discovered, 
while 619 extra-cardiac findings (2.8 per patient) were 
detected in 80% of patients. Thirty-two percent of the 
619 extracardiac findings were classified as “clinically 
significant”, including 2 cases of previously unknown 
cancers (esophageal and pulmonary, respectively; 0.9% 
of patients) and a newly diagnosed aortic dissection. 
The authors explained the relatively high incidence of 
extra-cardiac findings with the detailed image and the 
advanced age of their patients[32].
Schietinger et al[33] reached analogous conclusions, 
finding extra-cardiac CFs in 69% of patients, the majority 
being pulmonary, and clinically significant CFs in 24% of 
patients at ECG-gated multidetector CT for PV evaluation. 
Martins et al[34] described a lower prevalence of CFs 
among 250 consecutive patients (23%). Half of the 76 
CFs were pulmonary, including 2 lung cancers (0.8% 
of patients) and 2 pulmonary fibroses. Several findings 
led to specific disease management, but no focused 
follow-up was performed in order to get information 
about the impact of reviewing the entire FOV on patients’ 
outcome[34].
Our group enrolled 173 patients referred for catheter 
ablation of AF. Fifty-six percent of the patients ha at least 
one CF, and 33% had clinically significant CFs warranting 
further follow-up or investigations. In 10% of them, the 
detection of a CF led to therapeutic decisions. Three cases 
of bronchogenic carcinoma were eventually diagnosed 
(1.7% of the study population)[35]. After publication of the 
study, two more cases of bronchogenic carcinoma were 
diagnosed during further follow-up chest CTs performed 
in patients with incidentally detected pulmonary nodules 
(unpublished data). All lung cancers detected among 
our patients were at a relatively early stage; therefore, 
curative treatment was possible in all the cases.
A B
Figure 1  Antero-posterior (A) and left lateral (B) view of three-dimensional reconstruction of the left atrium and pulmonary veins after merging the cardiac 
computed tomography with the electroanatomical map created with the Carto 3 system (Biosense Webster, Inc., Diamond Bar, CA, United States). Note the 
ablation tags (red dots) placed around the pulmonary vein ostia on the computed tomography reconstruction. In the left lateral view, the narrow ridge between the left-
sided pulmonary veins and the left atrial appendage can be appreciated (white dashed line).
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In summary, the proportion of patients with CFs is very 
high among the reported studies of cardiac CT performed 
for AF catheter ablation. Incidental findings requiring 
further investigations or follow-up are also quite frequent. 
Rather consistently, almost half of all collateral findings 
are represented by pulmonary nodules. Malignancy is 
diagnosed in a percentage ranging from 0% to 1.7% of 
patients.
REPORTING AND FOLLOWING UP 
COLLATERAL FINDINGS: AN OPEN 
DEBATE
Because of the large diffusion of AF catheter ablations, 
an increasing number of cardiac CT is being performed 
worldwide. The number of reported CFs is increasing, 
due to the growing number of cardiac CT performed and 
to the improved spatial resolution of the CT scanners. 
The main problem in reporting CFs is the subsequent 
flow of further investigations and procedures that are 
performed in order to rule out potentially deleterious 
pathologies. On the one hand, one should always keep in 
mind that in some cases, the detection of an early stage 
malignant disease might allow appropriate treatment and 
prolong or save a patient’s life. However, to date robust 
data regarding the potential clinical benefits of reporting 
and following-up CFs is still lacking, and it has not been 
shown that reporting CFs may change the course of 
the disease or prolong survival, especially in the case of 
metastatic cancers or pathologies with an unpredictable 
natural history. The risk of undesirable effects carried by 
additional procedures, such as contrast medium-induced 
complications or the lifetime risk of ionizing radiation 
exposure-related cancer, must be kept in mind as well. 
This hinders the development of a widely accepted 
approach to such findings[36]. As a consequence, there is 
still disagreement about the appropriateness of reviewing 
and reporting extra-cardiac CFs during cardiac CT 
studies[37,38].
Once a CF is reported, there is also uncertainty about 
the decision to follow-up such findings over time. Some 
CFs are promptly deemed insignificant, that is, they do 
not require any additional examination. The dilemma 
about CFs follow-up arises when so-called “clinically 
significant collateral findings” are detected. While the 
anxiety for medico-legal implications from underreporting 
incidental findings would lead to describe and follow-up 
any lesion that is found in the FOV, some concern has 
been raised about increased financial burden in front of 
A B
Figure 2  Examples of collateral findings detected with the preprocedural cardiac computed tomography. A: Pulmonary thromboembolism involving principal 
branch of right pulmonary artery (red arrow); B: Classic “polka dotted” appearance due to the thickened vertebral trabeculae, highly suspicious for vertebral 
hemangioma (red arrow). 
A B
Figure 3  Examples of collateral findings detected with the preprocedural cardiac computed tomography. A: Ostium primum atrial septal defect (red arrow); B: 
Abnormal dilated vessels (red arrow) diagnostic for pulmonary arterovenous malformation located in the lower lobe of the right lung. 
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detected collateral findings (mostly extracardiac). 
Collateral findings are very frequently detected during 
cardiac CT studies, and a consistent proportion of them 
may require further investigations or follow-up. The 
optimal strategy to manage CFs is still debated, since 
most CFs are eventually found to be benign at the 
end of a diagnostic process which implies an increased 
financial burden and, in some cases, even some clinical 
risks for the patient. Moreover, a real clinical benefit of 
incidentally detecting malignant diseases has not been 
demonstrated. However, the risk of missing an early 
stage malignant disease should be considered while 
deciding whether reporting and following-up CFs or not. 
Almost all the studies published so far reported some 
malignant cancers, which could be treated after being 
serendipitously diagnosed by cardiac CT. We therefore 
advise a thorough inspection of the entire irradiated FOV, 
as well as a strict cooperation between cardiologists and 
radiologists for a comprehensive examination of cardiac 
CTs, in order to avoid missing important diseases in the 
examined FOV.
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